Bioresorbable Stents

Bioresorbable Stents
Global Bioresorbable Stents Market to Reach $990.5 Million by 2030
The global market for Bioresorbable Stents estimated at US$390.2 Million in the year 2022, is projected to reach a revised size of US$990.5 Million by 2030, growing at a CAGR of 12.4% over the period 2022-2030. Polymer-based, one of the segments analyzed in the report, is projected to record 13.1% CAGR and reach US$729.2 Million by the end of the analysis period. Growth in the Metal-Based segment is estimated at 10.5% CAGR for the next 8-year period.

Select Competitors (Total 25 Featured) - Abbott Laboratories, Inc.Boston Scientific CorporationBiotronik SE & Co. KGEurocor GmbHBiosensors International Group Ltd.Elixir Medical CorporationInSitu Technologies, Inc.Kyoto Medical Planning Co., Ltd.Medinol Ltd.Lepu Medical Technology (Beijing) Co., Ltd.Alvimedica Saglik Ekipmanlari Pazarlama Satis ve Dagitim A.S.Meril Life Sciences Pvt., Ltd.Arterial Remodeling Technologies SAiVascular S.L.UEndocor GmbHPlease note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.